164 related articles for article (PubMed ID: 15789362)
1. Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma.
Mizutani K; Onda M; Asaka S; Akaishi J; Miyamoto S; Yoshida A; Nagahama M; Ito K; Emi M
Cancer; 2005 May; 103(9):1785-90. PubMed ID: 15789362
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
J Cancer Res Clin Oncol; 2007 Apr; 133(4):213-8. PubMed ID: 17072649
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth.
Onda M; Akaishi J; Asaka S; Okamoto J; Miyamoto S; Mizutani K; Yoshida A; Ito K; Emi M
Br J Cancer; 2005 Jun; 92(12):2216-24. PubMed ID: 15956966
[TBL] [Abstract][Full Text] [Related]
5. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
[TBL] [Abstract][Full Text] [Related]
7. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
Hao F; Zhu Q; Lu L; Sun S; Huang Y; Zhang J; Liu Z; Miao Y; Jiao X; Chen D
Oncol Res; 2020 Sep; 28(4):345-355. PubMed ID: 32138807
[TBL] [Abstract][Full Text] [Related]
8. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer.
Pallante P; Federico A; Berlingieri MT; Bianco M; Ferraro A; Forzati F; Iaccarino A; Russo M; Pierantoni GM; Leone V; Sacchetti S; Troncone G; Santoro M; Fusco A
Cancer Res; 2008 Aug; 68(16):6770-8. PubMed ID: 18701502
[TBL] [Abstract][Full Text] [Related]
9. Targeted inhibition of long non-coding RNA H19 blocks anaplastic thyroid carcinoma growth and metastasis.
Zhang H; Yu Y; Zhang K; Liu X; Dai Y; Jiao X
Bioengineered; 2019 Dec; 10(1):306-315. PubMed ID: 31299871
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.
Takakura S; Mitsutake N; Nakashima M; Namba H; Saenko VA; Rogounovitch TI; Nakazawa Y; Hayashi T; Ohtsuru A; Yamashita S
Cancer Sci; 2008 Jun; 99(6):1147-54. PubMed ID: 18429962
[TBL] [Abstract][Full Text] [Related]
11. Thyroid Follicular Cell Loss of Differentiation Induced by MicroRNA miR-17-92 Cluster Is Attenuated by CRISPR/Cas9n Gene Silencing in Anaplastic Thyroid Cancer.
Fuziwara CS; Saito KC; Kimura ET
Thyroid; 2020 Jan; 30(1):81-94. PubMed ID: 31578932
[No Abstract] [Full Text] [Related]
12. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
13. Altered gene expression profiles by sodium/iodide symporter gene transfection in a human anaplastic thyroid carcinoma cell line using a radioactive complementary DNA microarray.
Gol Choe J; Kim YR; Kim KN; Choo HJ; Shin JH; Lee YJ; Chung JK; Kim MK
Nucl Med Commun; 2005 Dec; 26(12):1155-62. PubMed ID: 16264365
[TBL] [Abstract][Full Text] [Related]
14. Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR.
Garg M; Kanojia D; Okamoto R; Jain S; Madan V; Chien W; Sampath A; Ding LW; Xuan M; Said JW; Doan NB; Liu LZ; Yang H; Gery S; Braunstein GD; Koeffler HP
J Clin Endocrinol Metab; 2014 Jan; 99(1):E62-72. PubMed ID: 24170107
[TBL] [Abstract][Full Text] [Related]
15. TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype.
Salerno P; Garcia-Rostan G; Piccinin S; Bencivenga TC; Di Maro G; Doglioni C; Basolo F; Maestro R; Fusco A; Santoro M; Salvatore G
J Clin Endocrinol Metab; 2011 May; 96(5):E772-81. PubMed ID: 21389145
[TBL] [Abstract][Full Text] [Related]
16. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
[TBL] [Abstract][Full Text] [Related]
17. Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.
Aust G; Hofmann A; Laue S; Rost A; Köhler T; Scherbaum WA
Thyroid; 1997 Oct; 7(5):713-24. PubMed ID: 9349574
[TBL] [Abstract][Full Text] [Related]
18. Expression of oncofetal fibronectin mRNA in thyroid anaplastic carcinoma.
Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
Jpn J Clin Oncol; 2007 Sep; 37(9):647-51. PubMed ID: 17704536
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a.
Pacifico F; Crescenzi E; Mellone S; Iannetti A; Porrino N; Liguoro D; Moscato F; Grieco M; Formisano S; Leonardi A
J Clin Endocrinol Metab; 2010 Mar; 95(3):1421-30. PubMed ID: 20061417
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer.
Morrison JA; Pike LA; Sams SB; Sharma V; Zhou Q; Severson JJ; Tan AC; Wood WM; Haugen BR
Mol Cancer; 2014 Mar; 13():62. PubMed ID: 24645981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
